Mohit Khera
 | The topic of this article may not meet Wikipedia's notability guideline for academics. (December 2023) |
Dr Mohit Khera | |
|---|---|
| Nationality | American |
| Occupation | Professor |
| Website | https://www.drmohitkhera.com/ |
Mohit Khera is an American medical doctor and academic known for his work in male and female sexual dysfunction and testosterone replacement therapy. He currently holds the F. Brantley Scott Chair in Urology at Baylor College of Medicine.[1] He is also the President of the Sexual Medicine Society of North America.[2] His research focuses on male infertility, sexual dysfunction, and declining testosterone levels in aging men. Among his contributions to the field, he has investigated methods for treating Peyronie's disease as well as helped set the AUA Guideline for the clinic strategy.[3]
References
[edit]- ^ "mkhera". Baylor College of Medicine. Retrieved 2023-08-12.
- ^ Khera, Mohit. "Board of Directors". SMSNA. Retrieved 2023-08-24.
- ^ Nehra, Ajay; Alterowitz, Ralph; Culkin, Daniel J.; Faraday, Martha M.; Hakim, Lawrence S.; Heidelbaugh, Joel J.; Khera, Mohit; Kirkby, Erin; McVary, Kevin T.; Miner, Martin M.; Nelson, Christian J.; Sadeghi-Nejad, Hossein; Seftel, Allen D.; Shindel, Alan W.; Burnett, Arthur L. (September 2015). "Peyronie's Disease: AUA Guideline". The Journal of Urology. 194 (3): 745–753. doi:10.1016/j.juro.2015.05.098. ISSN 1527-3792. PMC 5027990. PMID 26066402.
| Authority control databases: Academics |
|---|
  | This article about an American scientist in academia is a stub. You can help Wikipedia by expanding it. |